Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 28, 2006; 12(32): 5140-5147
Published online Aug 28, 2006. doi: 10.3748/wjg.v12.i32.5140
Published online Aug 28, 2006. doi: 10.3748/wjg.v12.i32.5140
Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa™) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects
Amalia Azzariti, Letizia Porcelli, Grazia Maria Simone, Angelo Paradiso, Clinical Experimental Oncology Laboratory, National Cancer Institute, Bari, Italy
Jian-Ming Xu, Beijing 307 Hospital Cancer Center, Beijing 100039, China
Author contributions: All authors contributed equally to the work.
Supported by grants from the Italian Association for Cancer Research (AIRC-2004) and from the Italian Ministry of Health, Project ex art.12, Region of Emilia Romagna RF02
Correspondence to: Angelo Paradiso, MD, Head Clinical Experimental Oncology Laboratory, National Cancer Institute, Via Amendola 209, 70125 Bari, Italy. a.paradiso@oncologico.bari.it
Telephone: +39-80-5555561 Fax: +39-80-5555561
Received: July 6, 2005
Revised: July 20, 2005
Accepted: July 28, 2005
Published online: August 28, 2006
Revised: July 20, 2005
Accepted: July 28, 2005
Published online: August 28, 2006
Core Tip